TY - JOUR
T1 - Serum soluble E-selectin levels decrease early during effective therapy in psoriatic patients
AU - Ameglio, F.
AU - Bonifati, C.
AU - Carducci, M.
AU - Trento, E.
AU - Mussi, A.
AU - Tomaselli, R.
AU - Onorati, M. T.
AU - Fazio, M.
PY - 1995
Y1 - 1995
N2 - Soluble endothelial leukocyte adhesion molecule-1 (sELAM-1 or sE-selectin) is the released isoform of the transmembrane E-selectin, a molecule involved in the leukocyte rolling on the endothelial surfaces. Previous reports showed serum increases of different membrane molecule levels in psoriatic patients and correlations between their serum values and the Psoriasis Area and Severity Index (PASI) scores, without-early significant serum decreases after effective therapy. Serum sE-selectin values were also higher in patients with active psoriasis. Using a commercially available ELISA kit, the sera of 10 patients (6 females and 4 males, median age 42.5 years, range 24-52, median PASI of 15.2, range 5.5-28.8) were studied before and during therapy (local calcipotriol, 5 patients and systemic: cyclosporin-A, 5 patients) at two, four, and eight weeks. Considering all the times of observation (40 pairs), serum sE-selectin values correlated highly with the PASI scores (R = 0.56, p = 0.0001) Moreover, the serum levels of this molecule decreased rapidly during therapy (p <0.05 after 2 weeks) and dropped even more during the subsequent weeks of treatment; as the
AB - Soluble endothelial leukocyte adhesion molecule-1 (sELAM-1 or sE-selectin) is the released isoform of the transmembrane E-selectin, a molecule involved in the leukocyte rolling on the endothelial surfaces. Previous reports showed serum increases of different membrane molecule levels in psoriatic patients and correlations between their serum values and the Psoriasis Area and Severity Index (PASI) scores, without-early significant serum decreases after effective therapy. Serum sE-selectin values were also higher in patients with active psoriasis. Using a commercially available ELISA kit, the sera of 10 patients (6 females and 4 males, median age 42.5 years, range 24-52, median PASI of 15.2, range 5.5-28.8) were studied before and during therapy (local calcipotriol, 5 patients and systemic: cyclosporin-A, 5 patients) at two, four, and eight weeks. Considering all the times of observation (40 pairs), serum sE-selectin values correlated highly with the PASI scores (R = 0.56, p = 0.0001) Moreover, the serum levels of this molecule decreased rapidly during therapy (p <0.05 after 2 weeks) and dropped even more during the subsequent weeks of treatment; as the
KW - PASI score
KW - Psoriasis
KW - sE-selectin
KW - Soluble membrane molecules
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=0028808532&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028808532&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0028808532
VL - 5
SP - 512
EP - 515
JO - European Journal of Dermatology
JF - European Journal of Dermatology
SN - 1167-1122
IS - 6
ER -